Apothecary Pharma LLC recalls Tirzepatide Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- Tirzepatide Injection
- Company
- Apothecary Pharma LLC
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 22 vials
- About this recall
- Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.